Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEE POTEF	1.63e-04	11	35	2	GO:0098973
Domain	Actin_CS	POTEE POTEF	3.80e-04	16	34	2	IPR004001
Domain	ACTINS_2	POTEE POTEF	4.30e-04	17	34	2	PS00432
Domain	Actin/actin-like_CS	POTEE POTEF	4.83e-04	18	34	2	IPR020902
Domain	ACTINS_ACT_LIKE	POTEE POTEF	5.39e-04	19	34	2	PS01132
Domain	Actin	POTEE POTEF	1.45e-03	31	34	2	IPR004000
Domain	Actin	POTEE POTEF	1.45e-03	31	34	2	PF00022
Domain	ACTIN	POTEE POTEF	1.45e-03	31	34	2	SM00268
Domain	zf-C2H2_6	ZNF506 ZNF429 ZNF486 ZNF253	2.44e-03	314	34	4	PF13912
Domain	HEAT	SF3B1 TNPO2	3.44e-03	48	34	2	PF02985
Domain	KRAB	ZNF506 ZNF429 ZNF486 ZNF253	3.91e-03	358	34	4	PS50805
Domain	KRAB	ZNF506 ZNF429 ZNF486 ZNF253	3.91e-03	358	34	4	PF01352
Domain	KRAB	ZNF506 ZNF429 ZNF486 ZNF253	4.35e-03	369	34	4	SM00349
Domain	KRAB	ZNF506 ZNF429 ZNF486 ZNF253	4.40e-03	370	34	4	IPR001909
Domain	HEAT	SF3B1 TNPO2	4.99e-03	58	34	2	IPR000357
Domain	Ank_2	POTEE CTTNBP2 POTEF	6.92e-03	215	34	3	PF12796
Domain	HEAT_REPEAT	SF3B1 TNPO2	7.19e-03	70	34	2	PS50077
Domain	Ank	POTEE CTTNBP2 POTEF	8.13e-03	228	34	3	PF00023
Domain	-	POTEE CTTNBP2 POTEF	1.02e-02	248	34	3	1.25.40.20
Domain	ANK	POTEE CTTNBP2 POTEF	1.06e-02	251	34	3	SM00248
Domain	ANK_REPEAT	POTEE CTTNBP2 POTEF	1.08e-02	253	34	3	PS50088
Domain	Ankyrin_rpt-contain_dom	POTEE CTTNBP2 POTEF	1.09e-02	254	34	3	IPR020683
Domain	ANK_REP_REGION	POTEE CTTNBP2 POTEF	1.09e-02	254	34	3	PS50297
Domain	Ankyrin_rpt	POTEE CTTNBP2 POTEF	1.18e-02	262	34	3	IPR002110
Domain	ZINC_FINGER_C2H2_2	ZNF512B ZNF506 ZNF429 ZNF486 ZNF253	1.24e-02	775	34	5	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF512B ZNF506 ZNF429 ZNF486 ZNF253	1.26e-02	777	34	5	PS00028
Domain	Znf_C2H2-like	ZNF512B ZNF506 ZNF429 ZNF486 ZNF253	1.39e-02	796	34	5	IPR015880
Domain	Znf_C2H2	ZNF512B ZNF506 ZNF429 ZNF486 ZNF253	1.45e-02	805	34	5	IPR007087
Domain	ZnF_C2H2	ZNF512B ZNF506 ZNF429 ZNF486 ZNF253	1.47e-02	808	34	5	SM00355
Pathway	KEGG_SPLICEOSOME	ACIN1 SF3B1 TCERG1 HNRNPM	5.81e-05	127	24	4	M2044
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	POTEE ACIN1 SF3B1 TCERG1 POTEF HNRNPM	4.74e-07	271	38	6	32433965
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEE POTEF	1.16e-06	2	38	2	19669888
Pubmed	Acinus-S' represses retinoic acid receptor (RAR)-regulated gene expression through interaction with the B domains of RARs.	ACIN1 RARB	1.16e-06	2	38	2	18250153
Pubmed	The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.	SF3B1 TCERG1 HNRNPM	2.72e-06	25	38	3	15456888
Pubmed	Evolution and expression of chimeric POTE-actin genes in the human genome.	POTEE POTEF	3.48e-06	3	38	2	17101985
Pubmed	Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.	PDCD11 ACIN1 TCERG1 HNRNPM	5.15e-06	104	38	4	26167872
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF512B CUL4B PDCD11 ACIN1 SF3B1 FANCM TCERG1 HNRNPM	7.33e-06	954	38	8	36373674
Pubmed	The murine interleukin-3 receptor alpha subunit gene: chromosomal localization, genomic structure, and promoter function.	RARB IL3RA	1.16e-05	5	38	2	7858255
Pubmed	Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.	FANCM TCERG1 HNRNPM	1.25e-05	41	38	3	15561718
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	CUL4B PDCD11 SF3B1 HNRNPM	1.86e-05	144	38	4	35681168
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	PDCD11 ACIN1 SF3B1 POTEF	6.98e-05	202	38	4	24639526
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	ACIN1 TCERG1 CLK1 HNRNPM	7.12e-05	203	38	4	35012549
Pubmed	Identification of phosphoproteins and their phosphorylation sites in the WEHI-231 B lymphoma cell line.	ACIN1 SF3B1 HNRNPM	8.99e-05	79	38	3	14729942
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	PDCD11 SF3B1 TCERG1 HNRNPM	9.89e-05	221	38	4	29991511
Pubmed	The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice.	GLRA3 SF3B1	1.05e-04	14	38	2	22937132
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	POTEE PDCD11 ACIN1 SF3B1 DYNC1LI2 HNRNPM	1.13e-04	711	38	6	33022573
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEE POTEF	1.21e-04	15	38	2	16824795
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	ACIN1 SF3B1 POTEF HNRNPM	1.45e-04	244	38	4	29884807
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ZNF512B ACIN1 SF3B1 TCERG1 CLK1 DYNC1LI2 HNRNPM	1.50e-04	1082	38	7	38697112
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	CUL4B SF3B1 TCERG1 HNRNPM	1.59e-04	250	38	4	33536335
Pubmed	Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.	ACIN1 SF3B1 HNRNPM	1.60e-04	96	38	3	25948554
Pubmed	RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.	PDCD11 HNRNPM	1.76e-04	18	38	2	27558965
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	ACIN1 SF3B1 TCERG1 POTEF HNRNPM	2.16e-04	506	38	5	30890647
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	POTEE SF3B1 POTEF DYNC1LI2 HNRNPM	2.30e-04	513	38	5	25798074
Pubmed	Comprehensive proteomic analysis of the human spliceosome.	SF3B1 TCERG1 HNRNPM	2.33e-04	109	38	3	12226669
Pubmed	Nuclear organization of nucleotide excision repair is mediated by RING1B dependent H2A-ubiquitylation.	PDCD11 SF3B1 HNRNPM	2.53e-04	112	38	3	28416769
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CUL4B ACIN1 SF3B1 TCERG1	2.55e-04	283	38	4	30585729
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	ZNF429 SF3B1 DYNC1LI2 HNRNPM	2.58e-04	284	38	4	29459677
Pubmed	TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins.	SF3B1 HNRNPM	2.65e-04	22	38	2	17803295
Pubmed	Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.	ACIN1 SF3B1 TCERG1	2.73e-04	115	38	3	17332742
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	PDCD11 ACIN1 SF3B1 HNRNPM	2.98e-04	295	38	4	26209609
Pubmed	Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex.	TCERG1 HNRNPM	3.43e-04	25	38	2	9731529
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	ACIN1 SF3B1 HNRNPM	3.91e-04	130	38	3	35545047
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	PDCD11 ACIN1 SF3B1 TCERG1 HNRNPM	4.13e-04	583	38	5	29844126
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZNF512B PDCD11 ACIN1 SF3B1 FANCM TCERG1 HNRNPM	4.46e-04	1294	38	7	30804502
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF506 ZNF429	4.63e-04	29	38	2	14563677
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	ACIN1 SF3B1 TCERG1 HNRNPM	4.66e-04	332	38	4	32786267
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	ZNF512B PDCD11 ACIN1 SF3B1 HNRNPM	4.89e-04	605	38	5	28977666
Pubmed	Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.	MAP3K13 RARB	4.96e-04	30	38	2	22837378
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	PDCD11 ACIN1 SF3B1 HNRNPM	5.50e-04	347	38	4	16033648
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	CUL4B PDCD11 SF3B1 TCERG1 HNRNPM	6.22e-04	638	38	5	33239621
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	CUL4B PDCD11 ACIN1 SF3B1 HNRNPM	6.35e-04	641	38	5	36057605
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	ZNF512B TCERG1 HNRNPM	6.65e-04	156	38	3	37108203
Pubmed	Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.	PDCD11 SF3B1 HNRNPM	7.03e-04	159	38	3	22751105
Pubmed	STRAP regulates alternative splicing fidelity during lineage commitment of mouse embryonic stem cells.	SF3B1 CLK1	7.15e-04	36	38	2	33230114
Pubmed	Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.	SF3B1 HNRNPM	7.15e-04	36	38	2	24147044
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	POTEE ACIN1 SF3B1 TCERG1 HNRNPM	7.25e-04	660	38	5	32780723
Pubmed	High-throughput analyses of hnRNP H1 dissects its multi-functional aspect.	ZNF512B PDCD11 ACIN1 ZCCHC2 TNPO2 DYNC1LI2	7.80e-04	1021	38	6	26760575
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	ACIN1 SF3B1 HNRNPM	8.39e-04	169	38	3	23084401
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	POTEE ACIN1 MAP9 SF3B1 POTEF PRX HNRNPM	8.47e-04	1442	38	7	35575683
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	ACIN1 SF3B1 TCERG1 DYNC1LI2	9.25e-04	399	38	4	35987950
Pubmed	Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.	PDCD11 ACIN1 SF3B1 TCERG1	9.60e-04	403	38	4	35253629
Pubmed	Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.	SF3B1 VPS13C	1.02e-03	43	38	2	26030138
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF486 ZNF253 HNRNPM	1.02e-03	181	38	3	37372979
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZNF429 LGMN ACIN1 MAP9 ZCCHC2 DYNC1LI2	1.06e-03	1084	38	6	11544199
Interaction	NEK4 interactions	CUL4B POTEE ACIN1 SF3B1 POTEF DYNC1LI2 HNRNPM	5.38e-05	582	35	7	int:NEK4
Interaction	CLUH interactions	ACIN1 TCERG1 CLK1 DYNC1LI2 HNRNPM	8.59e-05	263	35	5	int:CLUH
Interaction	THRAP3 interactions	ACIN1 MAP9 SF3B1 CLK1 TNPO2 HNRNPM	1.03e-04	443	35	6	int:THRAP3
Interaction	ADAR interactions	POTEE ACIN1 CLK1 POTEF HNRNPM	1.27e-04	286	35	5	int:ADAR
Interaction	ALKAL2 interactions	POTEE LTK	1.60e-04	11	35	2	int:ALKAL2
Interaction	DDX23 interactions	ZNF512B PDCD11 ACIN1 SF3B1 TCERG1 CLK1	1.60e-04	480	35	6	int:DDX23
Interaction	SNRPA interactions	CUL4B ACIN1 LTK SF3B1 TCERG1 HNRNPM	1.63e-04	482	35	6	int:SNRPA
Interaction	SF1 interactions	CUL4B SF3B1 TCERG1 TNPO2 HNRNPM	1.69e-04	304	35	5	int:SF1
Interaction	ADARB1 interactions	PDCD11 ACIN1 SF3B1 TCERG1 POTEF HNRNPM	1.77e-04	489	35	6	int:ADARB1
Interaction	MIR138-1 interactions	PDCD11 SF3B1 HNRNPM	2.23e-04	68	35	3	int:MIR138-1
Interaction	MIR9-3 interactions	PDCD11 SF3B1 HNRNPM	2.43e-04	70	35	3	int:MIR9-3
Interaction	PRP4K interactions	ACIN1 SF3B1 TCERG1 CLK1 HNRNPM	2.44e-04	329	35	5	int:PRP4K
Interaction	MIR29B2 interactions	PDCD11 SF3B1 HNRNPM	2.53e-04	71	35	3	int:MIR29B2
Interaction	MIR140 interactions	PDCD11 SF3B1 HNRNPM	2.53e-04	71	35	3	int:MIR140
Interaction	MIR122 interactions	PDCD11 SF3B1 HNRNPM	2.53e-04	71	35	3	int:MIR122
Interaction	SMC5 interactions	ZNF512B CUL4B PDCD11 ACIN1 SF3B1 FANCM TCERG1 HNRNPM	2.54e-04	1000	35	8	int:SMC5
Interaction	MIR29B1 interactions	PDCD11 SF3B1 HNRNPM	2.75e-04	73	35	3	int:MIR29B1
Interaction	MIR18A interactions	PDCD11 SF3B1 HNRNPM	2.75e-04	73	35	3	int:MIR18A
Interaction	MIR20A interactions	PDCD11 SF3B1 HNRNPM	2.86e-04	74	35	3	int:MIR20A
Interaction	MIR15A interactions	PDCD11 SF3B1 HNRNPM	2.97e-04	75	35	3	int:MIR15A
Interaction	RRS1 interactions	PDCD11 ACIN1 LTK SF3B1 HNRNPM	3.04e-04	345	35	5	int:RRS1
Interaction	MIR16-1 interactions	PDCD11 SF3B1 HNRNPM	3.09e-04	76	35	3	int:MIR16-1
Interaction	MIR199A2 interactions	PDCD11 SF3B1 HNRNPM	3.09e-04	76	35	3	int:MIR199A2
Interaction	MIR429 interactions	PDCD11 SF3B1 HNRNPM	3.09e-04	76	35	3	int:MIR429
Interaction	MIR7-3 interactions	PDCD11 SF3B1 HNRNPM	3.09e-04	76	35	3	int:MIR7-3
Interaction	SRRM1 interactions	CUL4B ACIN1 SF3B1 CLK1 HNRNPM	3.16e-04	348	35	5	int:SRRM1
Interaction	MIR9-2 interactions	PDCD11 SF3B1 HNRNPM	3.21e-04	77	35	3	int:MIR9-2
Interaction	MIR200A interactions	PDCD11 SF3B1 HNRNPM	3.21e-04	77	35	3	int:MIR200A
Interaction	MIR92A1 interactions	PDCD11 SF3B1 HNRNPM	3.34e-04	78	35	3	int:MIR92A1
Interaction	MIR451A interactions	PDCD11 SF3B1 HNRNPM	3.34e-04	78	35	3	int:MIR451A
Interaction	MIR98 interactions	PDCD11 SF3B1 HNRNPM	3.34e-04	78	35	3	int:MIR98
Interaction	MIR222 interactions	PDCD11 SF3B1 HNRNPM	3.47e-04	79	35	3	int:MIR222
Interaction	MIR206 interactions	PDCD11 SF3B1 HNRNPM	3.47e-04	79	35	3	int:MIR206
Interaction	MIR1-2 interactions	PDCD11 SF3B1 HNRNPM	3.47e-04	79	35	3	int:MIR1-2
Interaction	MIR34C interactions	PDCD11 SF3B1 HNRNPM	3.47e-04	79	35	3	int:MIR34C
Interaction	CLK2 interactions	ACIN1 FANCM CLK1 HNRNPM	3.52e-04	195	35	4	int:CLK2
Interaction	MIR143 interactions	PDCD11 SF3B1 HNRNPM	3.60e-04	80	35	3	int:MIR143
Interaction	MIR145 interactions	PDCD11 SF3B1 HNRNPM	3.73e-04	81	35	3	int:MIR145
Interaction	MIR10B interactions	PDCD11 SF3B1 HNRNPM	3.87e-04	82	35	3	int:MIR10B
Interaction	MIR106A interactions	PDCD11 SF3B1 HNRNPM	4.01e-04	83	35	3	int:MIR106A
Interaction	SF3B1 interactions	ACIN1 SF3B1 TCERG1 CLK1 TNPO2 HNRNPM	4.06e-04	571	35	6	int:SF3B1
Interaction	SRSF11 interactions	CUL4B ACIN1 TCERG1 CLK1	4.10e-04	203	35	4	int:SRSF11
Interaction	MIR31 interactions	PDCD11 SF3B1 HNRNPM	4.15e-04	84	35	3	int:MIR31
Interaction	MIR199A1 interactions	PDCD11 SF3B1 HNRNPM	4.15e-04	84	35	3	int:MIR199A1
Interaction	MIR200B interactions	PDCD11 SF3B1 HNRNPM	4.15e-04	84	35	3	int:MIR200B
Interaction	MIR7-2 interactions	PDCD11 SF3B1 HNRNPM	4.15e-04	84	35	3	int:MIR7-2
Interaction	MIR16-2 interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR16-2
Interaction	MIR107 interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR107
Interaction	MIR17 interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR17
Interaction	MIR18B interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR18B
Interaction	MIR93 interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR93
Interaction	MIR9-1 interactions	PDCD11 SF3B1 HNRNPM	4.30e-04	85	35	3	int:MIR9-1
Interaction	MIR20B interactions	PDCD11 SF3B1 HNRNPM	4.45e-04	86	35	3	int:MIR20B
Interaction	SON interactions	ACIN1 MAP3K13 SF3B1 HNRNPM	4.49e-04	208	35	4	int:SON
Interaction	SLFN11 interactions	POTEE SF3B1 TCERG1 POTEF HNRNPM	4.51e-04	376	35	5	int:SLFN11
Interaction	MIR29A interactions	PDCD11 SF3B1 HNRNPM	4.60e-04	87	35	3	int:MIR29A
Interaction	MIR141 interactions	PDCD11 SF3B1 HNRNPM	4.76e-04	88	35	3	int:MIR141
Interaction	MIR138-2 interactions	PDCD11 SF3B1 HNRNPM	4.76e-04	88	35	3	int:MIR138-2
Interaction	FANCC interactions	PDCD11 FANCM TCERG1	4.92e-04	89	35	3	int:FANCC
Interaction	MIR29C interactions	PDCD11 SF3B1 HNRNPM	4.92e-04	89	35	3	int:MIR29C
Interaction	MIR221 interactions	PDCD11 SF3B1 HNRNPM	5.08e-04	90	35	3	int:MIR221
Interaction	MIR92A2 interactions	PDCD11 SF3B1 HNRNPM	5.08e-04	90	35	3	int:MIR92A2
Interaction	MIR1-1 interactions	PDCD11 SF3B1 HNRNPM	5.08e-04	90	35	3	int:MIR1-1
Interaction	MIR200C interactions	PDCD11 SF3B1 HNRNPM	5.25e-04	91	35	3	int:MIR200C
Interaction	GRWD1 interactions	CUL4B PDCD11 SF3B1 TCERG1 HNRNPM	5.32e-04	390	35	5	int:GRWD1
Interaction	MIR155 interactions	PDCD11 SF3B1 HNRNPM	5.42e-04	92	35	3	int:MIR155
Interaction	MIR128-1 interactions	PDCD11 SF3B1 HNRNPM	5.42e-04	92	35	3	int:MIR128-1
Interaction	MIR214 interactions	PDCD11 SF3B1 HNRNPM	5.59e-04	93	35	3	int:MIR214
Interaction	MIR205 interactions	PDCD11 SF3B1 HNRNPM	5.59e-04	93	35	3	int:MIR205
Interaction	MIR19B2 interactions	PDCD11 SF3B1 HNRNPM	5.77e-04	94	35	3	int:MIR19B2
Interaction	MIRLET7F1 interactions	PDCD11 SF3B1 HNRNPM	5.77e-04	94	35	3	int:MIRLET7F1
Interaction	MIRLET7A2 interactions	PDCD11 SF3B1 HNRNPM	6.14e-04	96	35	3	int:MIRLET7A2
Interaction	EED interactions	ZNF512B CUL4B PDCD11 LGMN ACIN1 SF3B1 TCERG1 VPS13C HNRNPM	6.26e-04	1445	35	9	int:EED
Interaction	MIRLET7C interactions	PDCD11 SF3B1 HNRNPM	6.33e-04	97	35	3	int:MIRLET7C
Interaction	MIR21 interactions	PDCD11 SF3B1 HNRNPM	6.33e-04	97	35	3	int:MIR21
Interaction	MIRLET7F2 interactions	PDCD11 SF3B1 HNRNPM	6.33e-04	97	35	3	int:MIRLET7F2
Interaction	MIR363 interactions	PDCD11 SF3B1 HNRNPM	6.33e-04	97	35	3	int:MIR363
Interaction	MIR106B interactions	PDCD11 SF3B1 HNRNPM	6.52e-04	98	35	3	int:MIR106B
Interaction	TAF15 interactions	CUL4B ACIN1 SF3B1 POTEF HNRNPM	6.53e-04	408	35	5	int:TAF15
Interaction	GCNT3 interactions	GLRA3 CUL4B	6.62e-04	22	35	2	int:GCNT3
Interaction	MIR128-2 interactions	PDCD11 SF3B1 HNRNPM	6.71e-04	99	35	3	int:MIR128-2
Interaction	MIR19A interactions	PDCD11 SF3B1 HNRNPM	6.91e-04	100	35	3	int:MIR19A
Interaction	MIRLET7B interactions	PDCD11 SF3B1 HNRNPM	7.12e-04	101	35	3	int:MIRLET7B
Interaction	MIRLET7D interactions	PDCD11 SF3B1 HNRNPM	7.12e-04	101	35	3	int:MIRLET7D
Interaction	MIR25 interactions	PDCD11 SF3B1 HNRNPM	7.12e-04	101	35	3	int:MIR25
Interaction	MIRLET7A3 interactions	PDCD11 SF3B1 HNRNPM	7.32e-04	102	35	3	int:MIRLET7A3
Interaction	MIR15B interactions	PDCD11 SF3B1 HNRNPM	7.53e-04	103	35	3	int:MIR15B
Interaction	MIR7-1 interactions	PDCD11 SF3B1 HNRNPM	7.53e-04	103	35	3	int:MIR7-1
Interaction	SUZ12 interactions	ZNF512B CUL4B PDCD11 ACIN1 SF3B1 TNPO2	7.66e-04	644	35	6	int:SUZ12
Interaction	MIR34A interactions	PDCD11 SF3B1 HNRNPM	7.75e-04	104	35	3	int:MIR34A
Interaction	MIR19B1 interactions	PDCD11 SF3B1 HNRNPM	7.75e-04	104	35	3	int:MIR19B1
Interaction	U2AF2 interactions	CUL4B ACIN1 SF3B1 TCERG1 CLK1 HNRNPM	8.10e-04	651	35	6	int:U2AF2
Interaction	SAFB interactions	CUL4B ACIN1 LTK CLK1	8.17e-04	244	35	4	int:SAFB
Interaction	MIRLET7E interactions	PDCD11 SF3B1 HNRNPM	8.19e-04	106	35	3	int:MIRLET7E
Interaction	ERRFI1 interactions	POTEE LTK POTEF	8.42e-04	107	35	3	int:ERRFI1
Interaction	INSL6 interactions	ACIN1 POTEF	8.57e-04	25	35	2	int:INSL6
Interaction	GGT1 interactions	CUL4B POTEF	8.57e-04	25	35	2	int:GGT1
Interaction	LINC01587 interactions	CUL4B VPS13C	8.57e-04	25	35	2	int:LINC01587
Interaction	MIRLET7A1 interactions	PDCD11 SF3B1 HNRNPM	8.65e-04	108	35	3	int:MIRLET7A1
Interaction	MIR34B interactions	PDCD11 SF3B1 HNRNPM	9.12e-04	110	35	3	int:MIR34B
Cytoband	2q21.1	POTEE POTEF	1.07e-03	58	38	2	2q21.1
Cytoband	19p13.11	ZNF506 ZNF253	1.69e-03	73	38	2	19p13.11
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEE POTEF	1.42e-04	13	25	2	685
GeneFamily	Ankyrin repeat domain containing	POTEE CTTNBP2 POTEF	4.38e-03	242	25	3	403
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF506 ZNF429 ZNF486 ZNF253	1.61e-02	718	25	4	28
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP9 FANCM TCERG1 VPS13C ABCG5	2.36e-07	159	38	5	1dde4d19cc0fde7ebbccb4c31bb845a92206021b
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ACIN1 SF3B1 ZCCHC2 CLK1 VPS13C	7.36e-07	200	38	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	ZNF512B CTTNBP2 FANCM ZNF253	1.61e-05	179	38	4	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	Sepsis-Leuk-UTI-Myeloid-tDC\|Leuk-UTI / Disease, condition lineage and cell class	LGMN MAP3K13 LTK IL3RA	2.44e-05	199	38	4	a2f154b15087803958a656d2a41b6d83fd37b32f
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAM157B FAM157A FAM157C	1.68e-04	126	38	3	730fc6dc740613b55e40e85334fa30330aa81c3b
ToppCell	Control-Myeloid_G-Neutrophil\|Control / Disease group, lineage and cell class	FAM157B FAM157A FAM157C	1.72e-04	127	38	3	d4af23d621b546785a077c367c3a66c59749fc15
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FAM157B FAM157A FAM157C	1.76e-04	128	38	3	9b3c57d559a5ed8d590dd89b64a57a3227d8c684
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAM157B FAM157A FAM157C	1.76e-04	128	38	3	58639cfdc70ff6764adcc5c1ce9eba9d033b8209
ToppCell	PBMC-Control-Myeloid-Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAM157B FAM157A FAM157C	1.81e-04	129	38	3	5578a9ef85706ab6a204ff31716e781ec3893b75
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAM157B FAM157A FAM157C	1.85e-04	130	38	3	cd6d8d646345b01ff0f04f776330a05b82e63bc9
ToppCell	Control-Myeloid_G\|Control / Disease group, lineage and cell class	FAM157B FAM157A FAM157C	1.89e-04	131	38	3	d5a53431f1f1b283fb9338b8561e6381f0227c62
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF512B CTTNBP2 FANCM	2.76e-04	149	38	3	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF512B CTTNBP2 FANCM	2.81e-04	150	38	3	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	Severe-B_naive-5\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RTKN2 ZNF486 IL3RA	2.98e-04	153	38	3	44572f87d403e314050ab935d2cd676c33d9c287
ToppCell	Severe-B_naive-5\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RTKN2 ZNF486 IL3RA	3.21e-04	157	38	3	a57ee4a6febdff3ee3d1645836695e6e7c055cf8
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	3.34e-04	159	38	3	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	3.34e-04	159	38	3	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	URO-Other\|URO / Disease, Lineage and Cell Type	POTEE LGMN IL3RA	3.40e-04	160	38	3	b0923e6bacfaba8ca40aa5706bf270eea0938b0a
ToppCell	URO-Other-RBC\|URO / Disease, Lineage and Cell Type	POTEE LGMN IL3RA	3.40e-04	160	38	3	558f3b0719e2461a69e1b93b08e21675e8d07a5a
ToppCell	Leuk-UTI-Myeloid-tDC\|Leuk-UTI / Disease, Lineage and Cell Type	LGMN LTK IL3RA	3.46e-04	161	38	3	51b9f60986ed2e8e2297d31c80462c3ab65a2e5e
ToppCell	VE-CD8-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	ZNF512B RTKN2 ABHD5	3.46e-04	161	38	3	a114f4f75859d9ef900e5146686438d051241429
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LGMN CTTNBP2 ABHD5	3.59e-04	163	38	3	a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTKN2 LTK LEKR1	3.72e-04	165	38	3	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTKN2 LTK LEKR1	3.72e-04	165	38	3	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	severe-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	LGMN MAP9 LTK	3.78e-04	166	38	3	ae38850fde549b8dd6fb12f0ef80b428ade50485
ToppCell	Influenza_Severe-pDC\|Influenza_Severe / Disease group and Cell class	LGMN MAP9 IL3RA	3.78e-04	166	38	3	b43a5cd4d28118cf6e56a435deb8ea9435608a90
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|World / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	3.85e-04	167	38	3	bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	3.92e-04	168	38	3	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	ZNF512B CTTNBP2 FAM157C	3.92e-04	168	38	3	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	healthy_donor-Myeloid-Monocytic-Neutrophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	FAM157B FAM157A FAM157C	3.92e-04	168	38	3	04259f5a9b067cd1b5619e34591e4b2fccc18535
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GLRA3 RTKN2 RARB	3.99e-04	169	38	3	319cba07263bf41fcbcbfecd117f91b729394241
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GLRA3 RTKN2 RARB	4.06e-04	170	38	3	5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d
ToppCell	droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LGMN RTKN2 LEKR1	4.06e-04	170	38	3	f664c7559e383b37845c123e41a3be316d869ba0
ToppCell	droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LGMN RTKN2 LEKR1	4.06e-04	170	38	3	0272eb1487c2545d4aa06f5d1cd77f823e1441e9
ToppCell	COVID_vent-Lymphocytic-Dendritic-pDC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	LGMN LTK IL3RA	4.13e-04	171	38	3	779c951d274ecbd1d546ac425d6c8e718623be5a
ToppCell	COVID_vent-Lymphocytic-Dendritic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	LGMN LTK IL3RA	4.13e-04	171	38	3	debbb071d260639b16269c94d172766908325c58
ToppCell	mild_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	4.20e-04	172	38	3	dab2f1a05c7df58d9387b13271b3f1f1583f9ac3
ToppCell	droplet-Lung-LUNG-1m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN RTKN2 LEKR1	4.27e-04	173	38	3	69b404e92aad3e6dff67e75466f073f20a71f13f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GLRA3 RTKN2 RARB	4.27e-04	173	38	3	9a2d42f8d9cb834856522661d524abb91c4637c5
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN RTKN2 LEKR1	4.27e-04	173	38	3	26bba58f9fb215d1d155504906cd77e8774f6936
ToppCell	severe_influenza-pDC\|severe_influenza / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	4.34e-04	174	38	3	d8d2ded5812ed3b3db4109585714a6513c13326a
ToppCell	mild_COVID-19-pDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	4.41e-04	175	38	3	b87f279a7519710146c49d6acccb0adedc195965
ToppCell	Thalamus-Neuronal-Excitatory\|Thalamus / BrainAtlas - Mouse McCarroll V32	MAP9 CTTNBP2 TCERG1	4.49e-04	176	38	3	d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GLRA3 RTKN2 RARB	4.49e-04	176	38	3	40993c41c1017b53039a337174fc56632b278609
ToppCell	myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell\|myeloid / Lineage, cell class and subclass	LGMN LTK IL3RA	4.64e-04	178	38	3	f75591988bbbeba073b66329a3437cb9b02f7648
ToppCell	Healthy/Control-pDC\|Healthy/Control / Disease group and Cell class	LGMN LTK IL3RA	4.64e-04	178	38	3	072b346c6bbd63f00efaceda486400a669b3ec48
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LGMN LTK IL3RA	4.72e-04	179	38	3	124da6f882968dc0d05f3edd8f3b4d61617cc214
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LGMN LTK IL3RA	4.72e-04	179	38	3	edc5ef693dc4e7ea70717b77fb908fc784dce3a2
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF429 RTKN2 FANCM	4.72e-04	179	38	3	c09c3eed43d1aa3b7aa8f3021e6f2737840cde16
ToppCell	ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, Lineage and Cell Type	LGMN LTK IL3RA	4.79e-04	180	38	3	be665e801512f6aaf6b3ecb26153bbdeb24619ac
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LTK IL3RA PRX	4.79e-04	180	38	3	7d4cb0ab9f96088cbc5db3096d884a1e5ce4cb5d
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|tumor_Lung / Location, Cell class and cell subclass	LTK IL3RA SPATA16	4.87e-04	181	38	3	c864ffeb9234b8c29754afc91c85a972889617f4
ToppCell	Healthy/Control-pDC\|World / Disease group and Cell class	LGMN LTK IL3RA	4.95e-04	182	38	3	97e0eee10905f2cf2bebb09e474629fc224f4397
ToppCell	droplet-Marrow-nan-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CUL4B IL3RA VPS13C	4.95e-04	182	38	3	bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LGMN LTK IL3RA	5.03e-04	183	38	3	df6fd0927b6e4cf9a1583969a68096e4bccfbace
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LGMN LTK IL3RA	5.03e-04	183	38	3	3b123571e10c132227aff65648b4b3c6acb4bd00
ToppCell	myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell\|World / Lineage, cell class and subclass	LGMN LTK IL3RA	5.11e-04	184	38	3	11619778bc773ecd1a9867330be04deaf324f31e
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LGMN IL3RA SPATA16	5.19e-04	185	38	3	cc5152d3055375172bdf84f442b233c8fbd422b3
ToppCell	Healthy_donor-pDC\|Healthy_donor / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	5.19e-04	185	38	3	7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8
ToppCell	healthy_donor-Lymphocytic-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	LGMN LTK IL3RA	5.27e-04	186	38	3	916f2aeea4989ba7a29e071e348a51010f010223
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.27e-04	186	38	3	b70cd94c651b56dcf2e55554533a5f1130845390
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.27e-04	186	38	3	31df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF429 RTKN2 FANCM	5.27e-04	186	38	3	bca5215d406f1785bf3a420201d5686071fcaca5
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.27e-04	186	38	3	eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCell	COVID-19_Severe-Myeloid-pDC\|COVID-19_Severe / Disease group, lineage and cell class	LGMN LTK IL3RA	5.27e-04	186	38	3	3db5ed69d49e5d79f990aca0295ddce4c297a05c
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.27e-04	186	38	3	b95be984e308d4f9061274a35995ec558d434e74
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LGMN LTK IL3RA	5.27e-04	186	38	3	8f7949740286f64e034d1eb533ebc2c6f71ae966
ToppCell	healthy_donor-Lymphocytic-Dendritic-pDC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	LGMN LTK IL3RA	5.27e-04	186	38	3	45f66619e45d590c7365a51782d4ac46b7d31fde
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.27e-04	186	38	3	95c7318e521fb6aa02e244b1e81e6b2a62107756
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Fos_(Layer_5a,_IEG+)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ABCG5 SPATA16	5.31e-04	40	38	2	b4c04100180790e1a53a15e8311e40015306c088
ToppCell	(0)_Myeloid-(01)_Dendritic_cell-(011)_pDC\|(01)_Dendritic_cell / immune cells in Peripheral Blood (logTPM normalization)	LGMN LTK IL3RA	5.36e-04	187	38	3	068502efa3f0ac4cea2fa4a18d1c2f686a4fba54
ToppCell	Healthy_donor-pDC\|World / disease group, cell group and cell class (v2)	LGMN LTK IL3RA	5.36e-04	187	38	3	aa2cc54487d3c5045ac0c93560944c5a55878e27
ToppCell	LAM-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	LGMN LTK IL3RA	5.36e-04	187	38	3	4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166
ToppCell	control-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LGMN LTK IL3RA	5.36e-04	187	38	3	c78aee98b32719aa45811b620fc97be1ecf5fd53
ToppCell	(0)_Myeloid-(011)_pDC\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	LGMN LTK IL3RA	5.44e-04	188	38	3	a81b5d840490d6a636fe168f8cff2c4984369f09
ToppCell	COVID-19_Severe-pDC-\|COVID-19_Severe / Disease condition and Cell class	LGMN LTK IL3RA	5.44e-04	188	38	3	9fd1116e31a05554850b8ed3c005ea660dfbd51c
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.44e-04	188	38	3	de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.44e-04	188	38	3	89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCell	COVID-19_Mild-pDC\|COVID-19_Mild / Disease condition and Cell class	LGMN LTK IL3RA	5.44e-04	188	38	3	62d33d2990d4a2d32bd0863147e47f656df1966e
ToppCell	COVID-19_Severe-pDC\|World / disease group, cell group and cell class	LGMN LTK IL3RA	5.44e-04	188	38	3	4c8e328b8206120708b05ea3c5865a0200dc5c4e
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LGMN LTK IL3RA	5.44e-04	188	38	3	879054b780378ae05be68e597c77c931bf0ade03
ToppCell	(7)_DC_1\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	LGMN MAP3K13 CTTNBP2	5.44e-04	188	38	3	832887afa4a54ed80906bc02176d646529c13398
ToppCell	COVID-19_Mild-pDC-\|COVID-19_Mild / Disease condition and Cell class	LGMN LTK IL3RA	5.44e-04	188	38	3	a75c2cf2f8dae343c13aaa66b637658b935ed10a
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GLRA3 RARB C1orf105	5.44e-04	188	38	3	b01cb642f8b2d83235706fec7477c15005094161
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / Disease condition and Cell class	LGMN LTK IL3RA	5.44e-04	188	38	3	475008f45673b42b75ef231c2df91f8b9adc9201
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.52e-04	189	38	3	209cae68d78c8f72479b169e27c3ff7e143adece
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.52e-04	189	38	3	a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCell	COVID-19_Mild-Myeloid-pDC\|COVID-19_Mild / Disease group, lineage and cell class	LGMN LTK IL3RA	5.52e-04	189	38	3	c6cfd6aa21c19f2c62d80218bbc924e14e82aada
ToppCell	Control-Myeloid-pDC\|Control / Disease group, lineage and cell class	LGMN LTK IL3RA	5.52e-04	189	38	3	46770b99da42f11f10cfc67cea8562342d60b867
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.52e-04	189	38	3	98ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.61e-04	190	38	3	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.61e-04	190	38	3	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	(0)_Myeloid-(01)_Dendritic_cell\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	LGMN LTK IL3RA	5.61e-04	190	38	3	e9507bb0c8ff3d071402731a9b8cfe1bba93fab0
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LGMN LTK IL3RA	5.61e-04	190	38	3	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.61e-04	190	38	3	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	LGMN LTK IL3RA	5.61e-04	190	38	3	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / disease group, cell group and cell class	LGMN LTK IL3RA	5.61e-04	190	38	3	c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LGMN LTK IL3RA	5.61e-04	190	38	3	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	Control-Myeloid-tDC\|Control / Disease, Lineage and Cell Type	LGMN LTK IL3RA	5.69e-04	191	38	3	5c1d6a52181eba01e9177d00fe941dda85ef7eb2
ToppCell	COVID-19_Moderate-pDC\|World / disease group, cell group and cell class	LGMN LTK IL3RA	5.69e-04	191	38	3	93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9
Disease	osteoarthritis, spine, body mass index	ABHD5 SPATA16	4.03e-05	8	36	2	EFO_0004340, EFO_1000787
Disease	Malignant Head and Neck Neoplasm	RARB FANCM	1.33e-03	44	36	2	C0278996
Disease	MYELODYSPLASTIC SYNDROME	SF3B1 FANCM	3.04e-03	67	36	2	C3463824
Disease	temporal horn of lateral ventricle volume measurement	MAP9 SPATA16	3.51e-03	72	36	2	EFO_0010333
Disease	pulmonary function measurement	MAP3K13 RARB	4.00e-03	77	36	2	EFO_0003892
Disease	Autism Spectrum Disorders	CTTNBP2 RARB	4.85e-03	85	36	2	C1510586
Disease	breast milk measurement	RARB ABHD5	7.44e-03	106	36	2	EFO_0009092

Protein segments in the cluster

Peptide	Gene	Start	Entry
IPRVKPEEMMDERPK	ACIN1	311	Q9UKV3
MERILGPLPKHMIQK	CLK1	391	P49759
PHMFPKILMKITDLR	RARB	371	P10826
PVQVMPKSPDEMRKV	GLRA3	406	O75311
APSMMKIRIIAPPKR	POTEF	1021	A5A3E0
PRPRSMLKKKSHMEE	MAP9	176	Q49MG5
PMHALPEEIQKMLPE	LEKR1	6	Q6ZMV7
PRMVPDGINPKLHKM	FANCM	626	Q8IYD8
DRPMHVKMDERALPK	HNRNPM	271	P52272
LREHIDKMKIPPEKM	DYNC1LI2	156	O43237
MDLHKPPGPLVLMVA	LTK	416	P29376
MRPLPKKHVEPMAVR	FAM157A	16	C9JC47
MRPLPKKHVEPMAVR	FAM157C	16	P0CG43
RPIIHPNAMEKLMKR	MAP3K13	521	O43283
APSMMKIRIIAPPKR	POTEE	1021	Q6S8J3
MRPLPKKHVEPMAVR	FAM157B	16	P0CG42
MQRLFPRIPHMKDPI	IL3RA	331	P26951
ADHMKKLPLTMPVKP	CTTNBP2	316	Q8WZ74
NIERMKHLKTLPMVP	ABCG5	341	Q9H222
VPMEVHLPPEMVKLQ	CUL4B	691	Q13620
MKIEIMSPRKPPLFL	RTKN2	406	Q8IZC4
PLPHIPLKNIMDVEM	SPATA16	111	Q9BXB7
PMLQRIGKMHPDIPV	ABHD5	276	Q8WTS1
MVQPRTMKIPDDPKA	C1orf105	91	O95561
MLRMKLPLKPTHPAE	ZCCHC2	1	Q9C0B9
PPMHLADILMKNPEK	PDCD11	481	Q14690
MEELKKLRHPTPTML	TCERG1	581	O14776
MHKMTPPIKDLLPRL	SF3B1	1006	O75533
MKLPKVPEMAVPEVR	PRX	476	Q9BXM0
PDMHLKPLMTELLKR	TNPO2	471	O14787
RHSLKKVPVMPKEMV	TEX13C	731	A0A0J9YWL9
KDPMEMRLPIRSPIK	VPS13C	3166	Q709C8
RKEVRLPMLHDPPKM	ZNF512B	26	Q96KM6
KPLTMERHEMIAKPP	ZNF253	61	O75346
EPCKMKRHEMVDEPP	ZNF429	61	Q86V71
PLTMKRHEMIAKPPV	ZNF486	71	Q96H40
KPLTMKRHEMIAKPP	ZNF506	61	Q5JVG8
PSPDVPLTIMKRKLM	LGMN	306	Q99538